The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dombrowski, K. E.
Right arrow Articles by Kapp, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dombrowski, K. E.
Right arrow Articles by Kapp, J. A.

The Journal of Immunology, Vol 154, Issue 12 6227-6237, Copyright © 1995 by American Association of Immunologists


ARTICLES

Antigen recognition by CTL is dependent upon ectoATPase activity

KE Dombrowski, Y Ke, LF Thompson and JA Kapp
Department of Veterans Affairs Medical Center, Amarillo, TX, USA.

Alloantigen-specific and OVA-specific CD8+ CTL were shown here to express an ectoATPase. These CTL also express an ectoADPase, but do not express detectable levels of an ectoAMPase. CD8+ CTL transported adenosine into their cytoplasm at a rate of 2.3 x 10(-11) mmol/min/10(5) cells. In contrast, adenosine uptake was 34-fold lower when ATP was used as the source of the nucleoside. This was consistent with the lack of ectoAMPase and suggests that the role of ectoATPase is not in the salvage of extracellular nucleotides. 5'-p- (fluorosulfonyl)benzoyl adenosine (5'-FSBA) is an ATP analogue affinity label that irreversibly inhibits CTL ectoATPase. Cells made ectoATPase activity deficient by modification with 5'-FSBA were not susceptible to potential lytic effects of extracellular ATP with less than 20% specific lysis at 20 mM of exogenous ATP. However, cells modified by 5'- FSBA were unable to kill their respective target cells. Complete inhibition of cell-mediated killing was observed with 1 mM 5'-FSBA. CTL modified by 5'-FSBA also failed to secrete TNF-alpha and IFN-gamma after activation by the appropriate Ag. Killing was also inhibited by 5'-adenylylimidodiphosphate (a nonhydrolyzable ATP analogue), but not by ATP, ADP, alpha, beta-methylene ADP (a nonhydrolyzable ADP analogue), AMP, or adenosine. Blockage of CTL activity by 5'-FSBA was not reversed by addition of ADP, suggesting that hydrolysis of ATP is an essential ectoATPase-mediated signal for CTL activation. These results suggest that ectoATPase is essential for Ag recognition and/or effector activities of CTL.


This article has been cited by other articles:


Home page
CVIHome page
R. A. Derks and K. D. Beaman
Regeneration and Tolerance Factor Prevents Bystander T-Cell Death Associated with Human Immunodeficiency Virus Infection
Clin. Vaccine Immunol., September 1, 2004; 11(5): 835 - 840.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. P. Langston, Y. Ke, A. T. Gewirtz, K. E. Dombrowski, and J. A. Kapp
Secretion of IL-2 and IFN-{gamma}, But Not IL-4, by Antigen-Specific T Cells Requires Extracellular ATP
J. Immunol., March 15, 2003; 170(6): 2962 - 2970.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. K. Nihei, A. C. C. de Carvalho, W. Savino, and L. A. Alves
Pharmacologic properties of P2Z/P2X7 receptor characterized in murine dendritic cells: role on the induction of apoptosis
Blood, August 1, 2000; 96(3): 996 - 1005.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Ma, Y. Ke, Q. Li, and J. A. Kapp
Bovine and Human Insulin Activate CD8+-Autoreactive CTL Expressing Both Type 1 and Type 2 Cytokines in C57BL/6 Mice
J. Immunol., January 1, 2000; 164(1): 86 - 92.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
Y. Ke, H. Ma, and J. A. Kapp
Antigen Is Required for the Activation of Effector Activities, whereas Interleukin 2 Is Required for the Maintenance of Memory in Ovalbumin-specific, CD8+ Cytotoxic T Lymphocytes
J. Exp. Med., January 5, 1998; 187(1): 49 - 57.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.